广西师范大学学报（自然科学版） ›› 2022, Vol. 40 ›› Issue (4): 173-179.doi: 10.16088/j.issn.1001-6600.2021022302

• 研究论文 • 上一篇    下一篇

基于CRISPR/Cas9系统构建Slfn2基因敲除的小鼠肺癌细胞系

陈莹1,2, 周祖平1,2,3, 邢兵1, 蒲仕明1,2,3*   

  1. 1. 广西师范大学生命科学学院, 广西桂林 541006;
    2. 广西高校干细胞与医药生物技术重点实验室(广西师范大学),广西桂林 541004;
    3. 广西师范大学生物医学研究中心,广西桂林 541004
  • 发布日期:2022-08-05
  • 通讯作者: 蒲仕明(1987—),男,四川南充人,广西师范大学助理研究员。E-mail: pushiming77@163.com
  • 基金资助:
    国家自然科学基金(81972700,61827819);广西自然科学基金(2018GXNSFBA281115);广西大学生创新创业训练计划(202010602052)

Construction of the Slfn2 Knockout Cell Lines in Lewis Lung Carcinoma Model Based on CRISPR/Cas9 System

CHEN Ying1,2, ZHOU Zuping1,2,3, XING Bing1, PU Shiming1,2,3*   

  1. 1. College of Life Sciences, Guangxi Normal University, Guilin Guangxi 541006, China;
    2. Guangxi Universities Key Laboratory of Stem Cell and Biopharmaceutical Technology (Guangxi Normal University), Guilin Guangxi 541004, China;
    3. Biomedical Research Center of Guangxi Normal University, Guilin Guangxi 541004, China
  • Published:2022-08-05

PDF (PC)

20

摘要： 为构建Slfn2-/-小鼠肺癌细胞系(Lewis lung carcinoma, LLC),本文利用CRISPR/Cas9技术,在CHOPCHOP网站筛选Slfn2基因的sgRNA序列,将合成的oligo序列退火后连接至pLenti CRISPR v2质粒中,并与pMD2.G、psPAX2共转染至293T细胞中包装慢病毒;利用包装的慢病毒感染LLC细胞,经筛选和单克隆培养,获取Slfn2-/-敲除的LLC细胞。结果显示SgRNA成功插入载体重组质粒;利用3质粒包装的慢病毒成功将LLC中的Slfn2基因突变,获得丢失8个碱基移码突变和丢失180个碱基缺失突变的Slfn2-/-小鼠肺癌细胞。可见,利用CRISPR/Cas9技术成功构建了Slfn2基因敲除的小鼠肺癌细胞。

关键词: 肺癌, 慢病毒, Slfn2, CRISPR/Cas9

Abstract: To construct a stable knocking down of Slfn2 expression cell line in Lewis lung carcinoma (LLC) using CRISPR/Cas9 system, a guide RNA (sgRNA) sequence targeting the Slfn2 gene was designed by using the CHOPCHOP website software. After ligation of the sgRNA to the lenti-CRISPR-v2 plasmid, the T293 cells were co-transfected with pLenti CRISPR v2-Slfn2, pMD2.G and psPAX2 to generate Lentivirus. The packaged lentivirus was used to infect LLC cells, and Slfn2-/-knockout LLC cells were obtained by screening and Monoclone culture. The results showed that the two SgRNAs were successfully inserted into the vector respectively. Slfn2 gene in LLC was successfully mutated by lentivirus packaged with three plasmids. Two Slfn2 knockout LLC cell lines were obtained, one with 8 bp deletion plus frameshift mutation and the other with 180 bp deletion mutation. The mouse lung cancer cells knocked out by Slfn2 gene were successfully constructed by CRISPR/Cas9 technology.

Key words: lung cancer, lentivirus, Slfn2, CRISPR/Cas9

中图分类号: 

  • R734.2
[1] BADE B C, DELA CRUZ C S. Lung cancer 2020: epidemiology, etiology, and prevention[J]. Clinics in Chest Medicine, 2020, 41(1): 1-24. DOI: 10.1016/j.ccm.2019.10.001.
[2]MAO Y S, YANG D, HE J, et al. Epidemiology of lung cancer[J]. Surgical Oncology Clinics of North America, 2016, 25(3): 439-445. DOI: 10.1016/j.soc.2016.02.001.
[3]肖佳龙, 郑莹. 全球肺癌的流行及预防进展[J].中国癌症杂志, 2020, 30(10): 721-725. DOI: 10.19401/j.cnki.1007-3639.2020.10.001.
[4]WAN G Q, LIU Y H, ZHU J, et al. SLFN5 suppresses cancer cell migration and invasion by inhibiting MT1-MMP expression via AKT/GSK-3β/β-catenin pathway[J]. Cellular Signalling, 2019, 59: 1-12. DOI: 10.1016/j.cellsig.2019.03.004.
[5]KAGAMI T, YAMADE M, SUZUKI T, et al. The first evidence for SLFN11 expression as an independent prognostic factor for patients with esophageal cancer after chemoradiotherapy[J]. BMC Cancer, 2020, 20(1): 1123. DOI: 10.1186/s12885-020-07574-x.
[6]LIU F R, ZHOU P T, WANG Q, et. al. The Schlafen family: complex roles in different cell types and virus replication[J]. Cell Biology International, 2018, 42(1): 2-8. DOI: 10.1002/cbin.10778.
[7]KATSOULIDIS E, MAVROMMATIS E, WOODARD J, et al. Role of interferon α (IFN α-inducible Schlafen-5 in regulation of anchorage-independent growth and invasion of malignant melanoma cells[J]. The Journal of Biological Chemistry, 2010, 285(51): 40333-40341. DOI: 10.1074/jbc.M110.151076.
[8]KATSOULIDIS E, CARAYOL N, WOODARD J, et al. Role of Schlafen 2 (SLFN2) in the generation of interferon alpha-induced growth inhibitory responses[J]. The Journal of Biological Chemistry, 2009, 284(37): 25051-25064. DOI: 10.1074/jbc.M109.030445.
[9]MAVROMMATIS E, ARSLAN A D, SASSANO A, et al. Expression and regulatory effects of murine Schlafen (Slfn) genes in malignant melanoma and renal cell carcinoma[J]. The Journal of Biological Chemistry, 2013, 288(46): 33006-33015. DOI: 10.1074/jbc.M113.460741.
[10]OH P S, PATEL V B, SANDERS M A, et al. Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells[J]. American Journal of Physiology. Gastrointestinal and Liver Physiology, 2011, 301(2): G347-G355. DOI: 10.1152/ajpgi.00403.2010.
[11]HORTON M R, POWELL J D. Quieting T cells with Slfn2[J]. Nature Immunology, 2010, 11(4): 281-282. DOI: 10.1038/ni0410-281.
[12]MARZI L, SZABOVA L, GORDON M, et al. The indenoisoquinoline top1 inhibitors selectively target homologous recombination-deficient and Schlafen 11-positive cancer cells and synergize with olaparib[J]. Clinical Cancer Research, 2019, 25(20): 6206-6216. DOI: 10.1158/1078-0432.
[13]SCHWARZ D A, KATAYAMA C D, HEDRICK S M. Schlafen, a new family of growth regulatory genes that affect thymocyte development[J]. Immunity, 1998, 9(5): 657-668. DOI: 10.1016/s1074-7613(00)80663-9.
[14]刘梦伊, 周乔丹, 胡迎春, 等. Schlafen2基因在细胞中的表达及其生物学特性研究[J]. 军事医学科学院院刊, 2008, 32(3): 228-231. DOI: 10.3969/j.issn.1674-9960.2008.03.007.
[1] 周俊, 陈舒曼, 邢兵, 陈雅静, 李银玲, 何柳, 周祖平, 蒲仕明. 正常来源CD4+CD25+细胞在小鼠肺癌模型中的抗肿瘤作用[J]. 广西师范大学学报（自然科学版）, 2022, 40(2): 191-199.
[2] 梅寒冰, 王威, 姚雪, 程联彪, 黄瑾. Hsp90抑制剂木犀草苷对非小细胞肺癌的体外抑制活性及作用机理研究[J]. 广西师范大学学报（自然科学版）, 2015, 33(3): 91-97.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 广西师范大学学报（自然科学版）编辑部
地址：广西桂林市三里店育才路15号　邮编：541004
电话：0773-5857325　E-mail: gxsdzkb@mailbox.gxnu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发